Delivery Order SPE2DB24D9313-SPE2DB24FFFHK
Award Date
9/25/24
Potential Completion Date
10/17/24
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the DLA's SPE2DB program. The $8,576.28 award is for the supply of Nexplanon 68 mg implants, a contraceptive product. DMS Pharmaceutical Group has a significant $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) to provide a comprehensive range of pharmaceutical items, including common medications and specialized drugs, to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of Nexplanon 68 mg contraceptive implants to the Defense Logistics Agency's (DLA) Medical Supply Chain division. The $5,717.52 firm fixed-price delivery order falls under a larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue orders for a comprehensive range of pharmaceutical products to support the medical supply needs of Department...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $3,573.45, is for the supply of Nexplanon 68 mg implants, a type of contraceptive device. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $9,437.70, is for the supply of 68 mg Nexplanon contraceptive implants to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order with a ceiling value of $4,288.14. The contract is for the supply of Nexplanon 68 mg implants, a contraceptive product, to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of Nexplanon 68 mg implants to the Defense Logistics Agency (DLA). The $2,144.07 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) the company holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a wide range of pharmaceutical products to fulfill the recurring...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order worth $10,720.35 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The IDC, titled SPE2DB, allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $8,576.28 under the Defense Logistics Agency's (DLA) SPE2DB program. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program, a $499,999,999 indefinite delivery contract that provides a range of pharmaceutical products and medical supplies to support the recurring medical needs of U.S. Department of Defense (DoD) healthcare facilities worldwide. The specific award, valued at $85,852.20, is for the delivery of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $30,661.50 firm fixed-price delivery order is for the supply of 4,554,751,713 units of the contraceptive implant Nexplanon. The contract does not have a set-aside designation. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...